ResearchAndMarkets.com adds Anti-GBM disease market report covering 7MM through 2036
AI Summary- ResearchAndMarkets.com added an Anti-GBM disease market report covering seven major markets through 2036.
- Kidney involvement occurs in approximately 90% of patients, while pulmonary involvement affects about 60%.
- The FDA granted veverimer Orphan Drug Designation for Anti-GBM disease in May 2025.